Key Developments: Sigma-Aldrich Corp (SIAL.OQ)
84.19USD
17 May 2013
$1.34 (+1.62%)
$82.85
$83.23
$84.26
$83.11
993,825
239,233
$84.26
$66.52
Latest Key Developments (Source: Significant Developments)
Sigma-Aldrich Corp Declares Quarterly Dividend
Sigma-Aldrich Corp announced that Board of Directors approved a quarterly cash dividend of $0.215 per share. The dividend is payable on June 14, 2013 to shareholders of record on May 31, 2013. Full Article
Sigma-Aldrich Corp Declares $0.215 Per Share Quarterly Dividend
Sigma-Aldrich Corp announced that Board of Directors approved a quarterly cash dividend of $0.215 per share. The dividend is payable on June 15, 2013 to shareholders of record on June 1, 2013. Full Article
Sigma-Aldrich Corp Reaffirms FY 2013 Guidance
Sigma-Aldrich Corp announced that for fiscal 2013, it expects organic sales growth to be in the low-to-mid single digit range and adjusted diluted EPS (excluding restructuring and other special charges) to be in a range of $4.10 to $4.20. The Company reported revenue of $2.27 billion for fiscal 2013. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $4.13 for fiscal 2013. Full Article
Sigma-Aldrich Corp Reaffirms FY 2013 EPS Guidance-Conference Call
Sigma-Aldrich Corp announced that it expects adjusted EPS for fiscal 2013 of $4.10 to $4.20. Full Article
Sigma-Aldrich Corp Revises FY 2013 Guidance-Conference Call
Sigma-Aldrich Corp announced that for fiscal 2013, it is looking at growing low- to mid-single digit organically and the full year EPS for 410 to 420 on an adjusted basis. The Company reported revenue of $2.27 billion for fiscal 2013. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.72 billion and EPS of $4.16 for fiscal 2013. Full Article
Sigma-Aldrich Corp Declares Increased Quarterly Dividend
Sigma-Aldrich Corp announced an increase of 7.5% in its quarterly cash dividend to $0.215 per share. The increased dividend was approved by the Company's Board of Directors on February 12, 2013 and is payable on March 15, 2013 to shareholders of record at the close of business on March 1, 2013. Full Article
Sigma-Aldrich Corp Issues FY 2013 Guidance; Revenue Guidance Below Analysts' Estimates
Sigma-Aldrich Corp announced that for fiscal 2013, it expects organic sales growth to be in the low to mid single digit and adjusted diluted earnings per share (EPS), excluding any restructuring charges or other special charges, is expected to be in a range of $4.10-$4.20. The Company reported revenue of $2.27 billion for fiscal 2013. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.75 billion and EPS of $4.15 for fiscal 2013. Full Article
Sigma-Aldrich Corp's SAFC Hitech Ltd to Form Joint Venture with Soulbrain Co Ltd
SAFC Hitech Ltd., a wholly-owned subsidiary of Sigma-Aldrich Corp has signed an agreement to create a 50/50 joint venture (JV) with Korean-based Soulbrain Co Ltd (Soulbrain). Soulbrain is a publicly traded specialty chemical company serving the flat panel display, semiconductor and electronic materials market. The joint venture, known as Soulbrain Sigma-Aldrich Ltd., is subject to customary closing conditions and is expected to be finalized early in the first quarter of 2013. The newly formed JV will serve the Korean market and will focus on developing and commercializing advanced metal organic precursor technologies used in the semiconductor and LED markets. Soulbrain will contribute certain electronic material product know-how, intellectual property (IP), and development personnel to the venture. SAFC Hitech Ltd. will contribute related manufacturing and product know-how and IP for metal organic compounds used to manufacture semiconductors and will license its technology to the joint venture for products used to manufacture light emitting diodes (LED). Full Article
Sigma-Aldrich Corp Declares Quarterly Dividend
Sigma-Aldrich Corp announced that it has approved a quarterly cash dividend of $0.20 per share. The dividend is payable on December 14, 2012 to shareholders of record on November 30, 2012. Full Article
Cyprotex plc Signs Licensing Agreement With Sigma-Aldrich Corp
Cyprotex plc announced licensing agreement with Sigma-Aldrich Corp Sigma Life Science has applied its exclusive CompoZr Zinc Finger Nuclease technology to the ADME-Tox field to create a range of proprietary cell-based assays for drug candidate screening. Cyprotex will add this technology to its screening services in an agreement that represents the first non-exclusive licence granted by Sigma for this novel technology. Cyprotex will be announcing the launch of these new services at the 18th North American International Society for the Study of Xenobiotics (ISSX) conference this month. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
